PEPTIDE BASED TARGETED RADIONUCLIDE THERAPIES; SCIENCE BEHIND THE SUCCESS.

The radionuclide therapies for solid and liquid malignancies are emerging field nowadays. The targeted radionuclide therapies have been in use since 1945. In the past 20 years, due to advancement in the nanotechnology and targeting cell receptors; radionuclide therapies have emerged as a subspecialt...

Full description

Bibliographic Details
Main Authors: Mohammed H Al Rowaily, Daniele Dondi, Marco Chinol, Iqbal Munir, Muaadh AlAsbahi
Format: Article
Language:English
Published: Shaukat Khanum Memorial Trust 2016-12-01
Series:Journal of Cancer and Allied Specialties
Online Access:http://journals.sfu.ca/jcas/index.php/jcas/article/view/92